The following data is part of a premarket notification filed by Lin-zhi International, Inc. with the FDA for Lzi Fentanyl Enzyme Immunoassay.
Device ID | K181159 |
510k Number | K181159 |
Device Name: | LZI Fentanyl Enzyme Immunoassay |
Classification | Enzyme Immunoassay, Opiates |
Applicant | Lin-Zhi International, Inc. 2945 Oakmead Village Court Santa Clara, CA 95051 |
Contact | Bernice Lin |
Correspondent | Bernice Lin Lin-Zhi International, Inc. 2945 Oakmead Village Court Santa Clara, CA 95051 |
Product Code | DJG |
CFR Regulation Number | 862.3650 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2018-05-01 |
Decision Date | 2018-12-03 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
B07603110 | K181159 | 000 |
B07603100 | K181159 | 000 |
00811727016416 | K181159 | 000 |
00811727016409 | K181159 | 000 |
00850624008353 | K181159 | 000 |